Triple-negative breast cancer (TNBC) is an aggressive breast cancer subtype that often fails to respond to treatments. Researchers at Jefferson Health's Sidney Kimmel Cancer Center (SKCC) have developed a novel therapeutic strategy that could revolutionize its treatment – and are challenging scientific beliefs in the process.

Understanding generational trauma and how therapists can be trained to help individuals cope.

Read the latest on the barriers to life after prison, a new treatment avenue for visceral pain, and how older people were cared for during the global pandemic.

Jefferson’s CEO Joseph G. Cacchione, MD is pleased to announce that John P. Mordach, has been named Executive Vice President and Chief Financial Officer of Jefferson, which consists of Thomas Jefferson University, Jefferson Health and Health Partners Plans. Effective March 20, 2023, Mordach will join the organization from Duke University Health System (DUHS) where he served as Senior Vice President, CFO and Treasurer for the $4.5 billion academic health system since 2020. 

With a projected 2.5 billion more people living in cities by 2050, the need to design sustainable cities has never been greater.

Researchers discover a potential therapeutic avenue against an aggressive form of prostate cancer. 

New research into making asthma and COPD medication more potent could also improve how long they work in patients who need frequent doses. 

Exploring the ways technology can improve collaborative treatment approaches for patients with opioid use disorder.

This year marks five years since the historic merger of two celebrated Philadelphia institutions — Thomas Jefferson University (Jefferson), a health sciences university that was founded in 1824 as the Jefferson Medical College, and Philadelphia University, a regional masters university and the nation’s first textile school founded in 1884.

The device improves upper limb function for patients with disability after stroke by stimulating the vagus nerve during rehab training.